HARP Insider Trading Activity - Harpoon Therapeutics Inc.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Harpoon Therapeutics Inc.

Goto Prev, 0, 1, 2, 3, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2021-01-11 Purchase	2021-08-12 4:15 pm	Harpoon Therapeutics Inc.	HARP	New Leaf Ventures III L.P. New Leaf Venture Associates III L.P. New Leaf Venture Management III L.L.C. New Leaf Biopharma Opportunities II L.P. New Leaf BPO Associates II L.P. New Leaf BPO Management II L.L.C 10% Owner	235,294	$17	$3,999,998	3,156,699 (Indirect)	View
2021-01-11 Purchase	2021-08-12 4:15 pm	Harpoon Therapeutics Inc.	HARP	HUNT RONALD Director 10% Owner	235,294	$17	$3,999,998	3,156,699 (Indirect)	View
2021-07-01 Sale	2021-07-06 6:01 pm	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$14	$140,000	73,854 (Direct)	View
2021-05-28 Sale	2021-06-02 6:09 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	57,494	$20.63	$1,186,190	6,328,095 (Indirect)	View
2021-05-26 Sale	2021-05-27 7:40 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	17,159	$20.22	$346,938	6,385,589 (Indirect)	View
2021-05-21 Sale	2021-05-24 8:11 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	15,907	$20.18	$321,030	6,402,748 (Indirect)	View
2021-05-18 Sale	2021-05-20 7:20 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	47,948	$20.49	$982,227	6,418,655 (Indirect)	View
2021-05-13 Sale	2021-05-17 5:23 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	16,421	$20.05	$329,314	6,466,603 (Indirect)	View
2021-05-10 Sale	2021-05-12 6:09 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	68,262	$21.04	$1,436,556	6,483,024 (Indirect)	View
2021-05-05 Sale	2021-05-06 4:05 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	10,172	$22.52	$229,107	6,551,286 (Indirect)	View
2021-04-30 Sale	2021-05-04 5:43 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	328,519	$22.48	$7,386,435	6,561,458 (Indirect)	View
2021-04-27 Sale	2021-04-29 5:46 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	130,143	$21.99	$2,861,368	6,889,977 (Indirect)	View
2021-04-21 Sale	2021-04-22 4:04 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	8,972	$18.97	$170,229	7,020,120 (Indirect)	View
2021-04-16 Sale	2021-04-20 6:07 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	38,152	$19.04	$726,550	7,029,092 (Indirect)	View
2021-04-13 Sale	2021-04-15 8:01 pm	Harpoon Therapeutics Inc.	HARP	MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd EVNIN LUKE Former 10% Owner	4,666	$20.16	$94,075	3,220,844 (Indirect)	View
2021-04-13 Sale	2021-04-15 8:00 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	38,556	$20.16	$777,359	7,067,244 (Indirect)	View
2021-04-09 Sale	2021-04-13 4:13 pm	Harpoon Therapeutics Inc.	HARP	GADICKE ANSBERT Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management LP MPM Oncology Impact Management GP LLC UBS Oncology Impact Fund L.P. 10% Owner	30,928	$21.9	$677,357	7,105,800 (Indirect)	View
2021-04-09 Sale	2021-04-13 4:12 pm	Harpoon Therapeutics Inc.	HARP	MPM BioVentures 2014 L.P. MPM ASSET MANAGEMENT LLC MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC Foley Todd EVNIN LUKE 10% Owner	12,796	$23.15	$296,261	3,225,510 (Indirect)	View
2021-04-01 Sale	2021-04-05 5:00 pm	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$20.45	$204,491	86,394 (Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2021-07-01 Exercise	2021-07-06 6:01 pm	N/A N/A	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$0.6	73,854 (Direct)	View
2021-07-01 Exercise	2021-07-06 6:01 pm	N/A 2026-04-06	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$0	73,854 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:09 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Viney Joanne L. Director	12,738	$0	12,738 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:07 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	BAILES JOSEPH S Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:05 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Robbins Andrew R Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:03 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Myers Scott Dunseth Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:02 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	EASTLAND JULIA MARIE Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 8:01 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	HUNT RONALD Director 10% Owner	14,825	$0	14,825 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 7:59 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	DRACHMAN JONATHAN G Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award(A)	2021-05-14 7:57 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Chin Mark Director	12,605	$0	12,605 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:59 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Colowick Alan Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:59 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Viney Joanne L. Director	12,820	$0	12,820 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:58 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	BAILES JOSEPH S Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:57 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Robbins Andrew R Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:56 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Myers Scott Dunseth Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:55 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	EASTLAND JULIA MARIE Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:54 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	HUNT RONALD Director 10% Owner	14,974	$0	14,974 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:53 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	DRACHMAN JONATHAN G Director	10,167	$0	10,167 (Direct)	View
2021-05-04 Option Award	2021-05-07 9:52 pm	N/A 2031-05-03	Harpoon Therapeutics Inc.	HARP	Chin Mark Director	13,184	$0	13,184 (Direct)	View
2021-04-01 Exercise	2021-04-05 5:00 pm	N/A N/A	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$0.6	86,394 (Direct)	View
2021-04-01 Exercise	2021-04-05 5:00 pm	N/A 2027-01-13	Harpoon Therapeutics Inc.	HARP	Wesche Holger Chief Scientific Officer	10,000	$0	86,394 (Direct)	View
2021-03-24 Option Award	2021-03-26 5:22 pm	N/A 2031-03-23	Harpoon Therapeutics Inc.	HARP	Colowick Alan Director	20,335	$0	20,335 (Direct)	View
2021-02-17 Exercise	2021-02-18 08:31 am	N/A N/A	Harpoon Therapeutics Inc.	HARP	Erbez Georgia Chief Financial Officer	25,000	$2.12	233,815 (Direct)	View
2021-02-17 Exercise	2021-02-18 08:31 am	N/A 2028-11-16	Harpoon Therapeutics Inc.	HARP	Erbez Georgia Chief Financial Officer	25,000	$0	233,815 (Direct)	View

(A) Indicate amendment filing.

Goto Prev, 0, 1, 2, 3, Next

Insider Trading & Ownership - Harpoon Therapeutics Inc. (HARP)